Search results for Monograph
FiltersOpen Government Canada
Portal
23 datasets for “Monograph”
- Open Government Canada
Product monograph brand safety updates
Health Canada | Santé CanadaUpdated 27 Jul 2022
Label safety assessment update from Health Canada
- HTML
- Open Government Canada
Notice: Phase II of the XML PM Project (Product Monograph in the Extensible Markup Language Format)
Health Canada | Santé CanadaUpdated 29 Dec 2021
Health Canada is working on a strategic approach to support the transition of all product monographs into the …
- HTML
- Open Government Canada
Non-prescription Drugs: Category IV Monographs
Health Canada | Santé CanadaUpdated 9 Sept 2021
A non-prescription drug Category IV Monograph outlines the permissible conditions of use and labelling requirements, such as …
- HTML
- Open Government Canada
Basic Product Monograph Information for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Health Canada | Santé CanadaUpdated 2 Dec 2023
This guidance is intended to harmonize and to update the prescribing information for nonsteroidal anti-inflammatory drugs () indicated …
- HTML
- Open Government Canada
Notice to stakeholders: Harmonizing fludeoxyglucose (F-18 FDG) product monographs
Health Canada | Santé CanadaUpdated 29 Dec 2021
… fludeoxyglucose (F-18 FDG) products in their product monographs. The modified wording aims to bring the indications and …
- HTML
- Open Government Canada
Guidance document: Product Monograph (2020)
Health Canada | Santé CanadaUpdated 7 Jul 2021
The purpose of this guidance document is to assist sponsors in developing product monographs with acceptable format and …
- HTML
- Open Government Canada
Non-prescription Drugs: Category IV Monographs
Health Canada | Santé CanadaUpdated 7 Jul 2021
A non-prescription drug Category IV Monograph outlines the permissible conditions of use and labelling requirements, such as …
- HTML
- Open Government Canada
Guidance for Industry - Product Monographs of Non-Contraceptive Estrogen/Progestin-Containing Products
Health Canada | Santé CanadaUpdated 7 Jul 2021
… This document is intended to help the pharmaceutical industry revise the content of the Product Monograph and associated …
- HTML
- Open Government Canada
Updated: Notice - Notification of Safety Labelling Changes to the Product Monographs of Pharmaceutical Drug Products
Health Canada | Santé CanadaUpdated 29 Dec 2021
Health Canada will continue to post a monthly table on the Department website which reflects updated and/or …
- HTML
- Open Government Canada
Basic Product Monograph Information for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Health Canada | Santé CanadaUpdated 7 Jul 2021
… Each Product Monograph is expected to contain objective, adequate and concise information on properties common to the active …
- HTML
- Open Government Canada
Haemodialysis Solutions
Health Canada | Santé CanadaUpdated 7 Jul 2021
This monograph applies to products in the form of liquid concentrate that are intended to be used for …
- HTML
- Open Government Canada
About Health Product Surveillance
Health Canada | Santé CanadaUpdated 30 Mar 2024
Health Canada makes sure that the known serious risks are written on the product label or product monograph …
- HTML
- Open Government Canada
Guidance Document: Tamper-resistance Formulations of Opioid Drug Products
Health Canada | Santé CanadaUpdated 7 Jul 2021
… with tamper-resistant properties and wish to include, in product monographs, scientific statements and claims regarding tamper-resistance.
- HTML
- Open Government Canada
Health Product InfoWatch – October 2021
Public Health Agency of Canada | Agence de la santé publique du CanadaUpdated 8 Nov 2021
Monthly recap of health product safety information. The following is a list of health product advisories, type I …
- HTML
- Open Government Canada
Drug Product Database - All Files
Health Canada | Santé CanadaUpdated 28 May 2025
The Drug Product Database (DPD) system captures information on Canadian human, veterinary and disinfectant products approved for use …
- ZIP
- HTML
- JSON
- XML
- Open Government Canada
Guidance for market authorization requirements for COVID-19 drugs: Labelling and post-market requirements
Health Canada | Santé CanadaUpdated 28 Jul 2022
A product monograph is a factual, scientific document on a drug product. It does not contain promotional material …
- HTML
- Open Government Canada
Ministry of Municipal Affairs and Housing library catalogue
Government of Ontario | Gouvernement de l'OntarioUpdated 10 Jun 2026
The InfoLink Library collection includes monographs, books, reports and periodicals. The catalogue contains information used by ministry staff …
- XLSX
- HTML
- Open Government Canada
NACI rapid response: Booster dose in long-term care residents and seniors living in other congregate settings
Public Health Agency of Canada | Agence de la santé publique du CanadaUpdated 5 Nov 2021
… People administering the vaccine should also be aware of the contents of the relevant product monograph. Recommendations for …
- HTML
- Open Government Canada
National Advisory Committee on Immunization (NACI) rapid response: Additional dose of COVID-19 vaccine in immunocompromised individuals following 1- or 2- dose primary series
Public Health Agency of Canada | Agence de la santé publique du CanadaUpdated 5 Nov 2021
… People administering the vaccine should also be aware of the contents of the relevant product monograph. Recommendations for …
- HTML
- Open Government Canada
Physiography of Southern Ontario
Natural Resources Canada | Ressources naturelles CanadaUpdated 14 Mar 2022
… They accompanied the monograph entitled The Physiography of Southern Ontario by L. J. Chapman and D. F. Putnam.
- JPG